Published in Childs Nerv Syst on March 06, 2015
Presentation and symptom interval in children with central nervous system tumors. A single-center experience. Childs Nerv Syst (2017) 0.75
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Parents' accounts of obtaining a diagnosis of childhood cancer. Lancet (2001) 2.62
Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA (2012) 2.45
Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97
Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol (2012) 1.88
Delay in the diagnosis of pediatric brain tumors. Am J Dis Child (1986) 1.83
Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain (2006) 1.74
Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr (1991) 1.71
Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer (2009) 1.57
Challenging issues in pediatric oncology. Nat Rev Clin Oncol (2011) 1.56
Why are brain tumours still being missed? Arch Dis Child (1996) 1.53
Identifying brain tumours in children and young adults. BMJ (2013) 1.48
A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol (2012) 1.44
Determinants of symptom interval in childhood cancer. Arch Dis Child (1993) 1.43
Functional outcome after low-grade astrocytoma treatment in childhood. Cancer (2006) 1.41
The presenting features of brain tumours: a review of 200 cases. Arch Dis Child (2006) 1.37
Clinical aspects and long-term prognosis of intracranial tumours in infancy and childhood. Dev Med Child Neurol (1976) 1.36
Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol (2003) 1.29
Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study. Neurosurgery (2002) 1.24
Children with brain tumor headaches. Distinguishing features. Am J Dis Child (1982) 1.22
Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol (2010) 1.22
Long-term sequelae in children after cerebellar astrocytoma surgery. Neurology (2004) 1.17
Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr Neurosurg (1997) 1.14
Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol (2010) 1.13
The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour. Arch Dis Child (2010) 1.09
Headaches and brain tumors. Am J Dis Child (1982) 1.06
Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood. J Clin Oncol (2009) 1.00
Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis? Cancer (1996) 1.00
Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr (2002) 0.98
Acute obstructive hydrocephalus and sudden death in children. Ann Emerg Med (1997) 0.96
Posterior fossa tumors in children: how long does it take to establish the diagnosis? Childs Nerv Syst (2007) 0.94
Relapses and remissions in brain stem tumours. Br Med J (1969) 0.93
Children with headache suspected of having a brain tumor: a cost-effectiveness analysis of diagnostic strategies. Pediatrics (2001) 0.92
Red flags in patients presenting with headache: clinical indications for neuroimaging. Br J Radiol (2003) 0.92
Pediatric midbrain tumors: a benign subgroup of brainstem gliomas. Pediatr Neurosurg (1995) 0.89
Low grade glial neoplasms. J Clin Neurosci (2003) 0.87
Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr (1991) 0.86
The epidemiology of headache among children with brain tumor. Headache in children with brain tumors. The Childhood Brain Tumor Consortium. J Neurooncol (1991) 0.86
Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr (2008) 0.86
Management of intrinsic gliomas of the tectal plate in children. A ten-year review. Pediatr Neurosurg (1999) 0.85
Plastic relocation of motor cortex in a patient with LGG (low grade glioma) confirmed by NBS (navigated brain stimulation). Acta Neurochir (Wien) (2012) 0.83
Clinical aspects and long-term prognosis in supratentorial tumors of infancy and childhood. Acta Neurol Scand (1978) 0.83
Spine and spinal cord tumours in children: a diagnostic and therapeutic challenge to healthcare systems. Arch Dis Child Educ Pract Ed (2010) 0.82
Low grade astrocytomas in the West of Scotland 1987-96: treatment, outcome, and cognitive functioning. Arch Dis Child (2001) 0.80
The clinical presentation of children with tumours affecting the anterior visual pathways. Eye (Lond) (1997) 0.79
Neuro-ophthalmic complications of raised intracranial pressure, hydrocephalus, and shunt malfunction. Neurosurg Clin N Am (1999) 0.78
Delay in diagnosis of primary intradural spinal cord tumors. Surg Neurol Int (2012) 0.78
A perivascular niche for brain tumor stem cells. Cancer Cell (2007) 11.55
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet (2012) 7.61
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol (2006) 5.96
Subtypes of medulloblastoma have distinct developmental origins. Nature (2010) 5.94
Radial glia cells are candidate stem cells of ependymoma. Cancer Cell (2005) 5.21
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol (2010) 4.94
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol (2006) 4.72
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet (2009) 4.52
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol (2010) 4.48
Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature (2010) 3.70
Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol (2004) 3.56
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol (2011) 3.56
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol (2009) 3.32
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell (2011) 2.87
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A (2009) 2.72
Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist (2004) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol (2005) 2.34
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol (2012) 2.34
Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. J Neurosurg (2006) 2.31
Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol (2009) 2.26
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol (2005) 2.19
Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Cancer (2005) 1.93
Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell (2009) 1.92
Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer (2003) 1.88
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol (2008) 1.87
The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma. Cancer Res (2009) 1.79
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Cancer Chemother Pharmacol (2014) 1.78
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell (2011) 1.78
High-grade astrocytoma in very young children. Pediatr Blood Cancer (2007) 1.77
ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res (2003) 1.71
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol (2007) 1.67
Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study. J Clin Oncol (2013) 1.66
Phase I study of everolimus in pediatric patients with refractory solid tumors. J Clin Oncol (2007) 1.61
Challenges and opportunities to advance pediatric neuro-oncology care in the developing world. Childs Nerv Syst (2015) 1.58
Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer (2009) 1.57
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma. Ophthalmology (2009) 1.54
A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Neurooncol (2013) 1.51
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer (2008) 1.48
Phase I study of combination topotecan and carboplatin in pediatric solid tumors. J Clin Oncol (2002) 1.47
Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology (2003) 1.45
Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol (2012) 1.44
Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys (2006) 1.44
Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol (2007) 1.42
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatr Blood Cancer (2014) 1.41
Improving the histopathologic diagnosis of pediatric malignancies in a low-resource setting by combining focused training and telepathology strategies. Pediatr Blood Cancer (2012) 1.39
Alexander disease: An important mimicker of focal brainstem glioma. Pediatr Blood Cancer (2009) 1.39
Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol (2005) 1.39
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. J Clin Oncol (2011) 1.39
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol (2006) 1.38
Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420. Clin Cancer Res (2007) 1.35
Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. Clin Cancer Res (2007) 1.34
Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol (2005) 1.31
Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer (2010) 1.30
Retinoblastoma: one world, one vision. Pediatrics (2008) 1.29
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (2014) 1.28
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol (2010) 1.27
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol (2012) 1.25
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res (2013) 1.23
Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol (2010) 1.22
UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan. J Clin Oncol (2007) 1.20
Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. Neuro Oncol (2012) 1.20
Atypical white matter volume development in children following craniospinal irradiation. Neuro Oncol (2005) 1.20
Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. AJNR Am J Neuroradiol (2004) 1.19
Young age may predict a better outcome for children with diffuse pontine glioma. Cancer (2008) 1.18
A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors. Clin Cancer Res (2003) 1.17
Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol (2012) 1.16
What's new in neuro-oncology? Recent advances in medulloblastoma. Eur J Paediatr Neurol (2003) 1.16
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol (2008) 1.15
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. BMC Cancer (2014) 1.14
Chemotherapy for malignant brain tumors of childhood. J Child Neurol (2008) 1.14
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol (2008) 1.13
Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study. AJNR Am J Neuroradiol (2002) 1.13
Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience. Cancer (2004) 1.13
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol (2013) 1.12
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer (2005) 1.12
Physical performance limitations among adult survivors of childhood brain tumors. Cancer (2010) 1.12
Early patterns of verbal memory impairment in children treated for medulloblastoma. Neuropsychology (2006) 1.11
Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. J Clin Oncol (2010) 1.10